Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Sept. 18 to Sept. 22, 2017.
GI & Endoscopy
Landos Biopharma completed a series A financing round raising $10 million.
A study from England-based Oxford University further validated Medial EarlySign's ColonFlag.
The FDA approved Bracco Diagnostics' Tagitol V oral suspension for adult patients undergoing virtual colonoscopy.
Allergan's board of directors authorized the company to buy back $2 billion in stock, while also committing to increasing its quarterly dividends and reaffirming its decision to pay down $3.75 billion in debt by 2018.
Daryl M. McClendon, MD, is a gastroenterologist at Anchorage-based Alaska Digestive and Liver Disease Clinic.
Salary.com reported data on gastroenterologists' salary from several human resources departments.
Penn State College of Medicine appointed Thomas Ma, MD, department of medicine chair for both Penn State College of Medicine and Penn State Health Milton S. Hershey Medical Center. All organizations are based in Hershey, Pa.
A study, published in Clinical Gastroenterology and Hepatology, examined factors that indicated inadequately prepared bowels before a colonoscopy.
Here are the five most popular gastroenterology and endoscopy stories for the week of Sept. 18 to Sept. 22, 2017.
